参考文献
[1] 张成珍, 张玉侠. 羟苯磺酸钙的应用进展[J]. 医药导报, 2012, 31(9): 1181-1184.
[2] Benakis A, Glasson B, Bouvier C A, et al. Metabolism and pharmacokinetics of calcium dobesilate in humans[J]. Therapie, 1974, 29(2): 211-219.
[3] 杨文波, 王红雁. 羟苯磺酸钙的药理作用及临床应用[J]. 现代医药卫生, 2012, 28(7): 1043-1044.
[4] Guo X, Hou L, Cheng X, et al. Strong negative interference by calcium dobesilate in sarcosine oxidase assays for serum creatinine involving the Trinder reaction[J]. Medicine, 2015, 94(23).
[5] Guo X, Zhao F, Yin Y, et al. Calcium dobesilate: a drug treatment for diabetic retinopathy can negatively interfere with the measurement of glycated albumin using the enzymatic method[J]. Clinica Chimica Acta, 2018, 483: 1-5.
[6] Guo X, Hou L, Yin Y, et al. Negative interferences by calcium dobesilate in the detection of five serum analytes involving Trinder reaction-based assays[J]. Plos one, 2018, 13(2): e0192440.
[7] Hoffmann W G G G E. Multicentre evaluation of an enzymatic method for creatinine determination using a sensitive colour reagent[J]. J. Clin. Chem. Clin. Biochem, 1986, 24(11): 889-902.
[8] Shen H, Chen K, Cao J. A new method for anti‐negative interference of calcium dobesilate in serum creatinine enzymatic analysis[J]. Journal of Clinical Laboratory Analysis, 2021, 35(9): e23928.
[9] Zhang T, Guo X, Hou L, et al. Effects of calcium dobesilate (CaD) interference on serum creatinine measurements: a national External Quality Assessment (EQA)-based educational survey of drug-laboratory test interactions[J]. Clinical Chemistry and Laboratory Medicine (CCLM), 2021, 59(1): 139-145.
[10] 戴莹洁, 周勇, 陈文举, 等. 羟苯磺酸钙对肌氨酸氧化酶法和苦味酸法检测肌酐的干扰[J]. 中国乡村医药, 2017 (15): 46-47.
[11] Tarasek D, Gąsowska-Bajger B, Wojtasek H. Mechanisms of interference of p-diphenols with the Trinder reaction[J]. Bioorganic Chemistry, 2020, 97: 103692.
[12] 陈墨馨, 俞明朝, 张宇, 等. 羟苯磺酸钙对血清肌酐测定干扰的研究进展[J]. 中国老年学杂志, 2021.
[13] 陈兴明, 李丹, 邴岩, 等. 部分还原性药物对 Trinder 反应的干扰[J]. 总装备部医学学报, 2010 (4): 233-235.